MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 4, 2015, Pages 357-363

  Wei, Longxiao ^b   Yuan, Menghui ^b   Zhou, Runsuo ^b   Bai, Qianrong ^b   Zhang, Wei ^b   Zhang, Ming ^a   Huang, Yong ^b   Shi, Le ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac hypertrophy; miR 101; Rab1a; Small GTPase

Indexed keywords

ANGIOTENSIN II; MICRORNA 101; MICRORNA; MIRN101 MICRORNA, RAT; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; RAB PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CARDIOMYOCYTE HYPERTROPHY; CELL ENLARGEMENT; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE OVEREXPRESSION; GENE TARGETING; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HYPERTROPHY; LIQUID SCINTILLATION COUNTING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RAB1A GENE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSVERSE ABDOMINAL AORTIC CONSTRICTION; ANIMAL; CARDIOMEGALY; CELL CULTURE; DISEASE MODEL; ECTOPIC EXPRESSION; GENETICS; METABOLISM; UPREGULATION;

ANIMALS; CARDIOMEGALY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ECTOPIC GENE EXPRESSION; MICRORNAS; MONOMERIC GTP-BINDING PROTEINS; MYOCYTES, CARDIAC; RAB1 GTP-BINDING PROTEINS; RATS; UP-REGULATION;

EID: 84928156132     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000203     Document Type: Article

References (26)

1. Tardiff JC. Cardiac hypertrophy: stressing out the heart. J Clin Invest. 2006;116:1467-1470.
2. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358:1370-1380.
3. Farh KK, Grimson A, Jan C, et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science. 2005;310:1817-1821.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
5. Guo F, Cogdell D, Hu L, et al. MiR-101 suppresses the epithelial-tomesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma. Oncol Rep. 2014;31:2021-2028.
6. Li X, Shi Y, Yin Z, et al. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma. J Transl Med. 2014;12:159.
7. Liang X, Liu Y, Zeng L, et al. MiR-101 inhibits the G1-to-s Phase transition of cervical cancer cells by targeting Fos. Int J Gynecol Cancer. 2014;24:1165-1172.
8. Pan Z, Sun X, Shan H, et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-beta1 pathway. Circulation. 2012;126:840-850.
9. Feng HJ, Ouyang W, Liu JH, et al. Global microRNA profiles and signaling pathways in the development of cardiac hypertrophy. Braz J Med Biol Res. 2014;47:361-368.
10. Han JJ, Hao J, Kim CH, et al. Quercetin prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Med Sci. 2009;71:737-743.
11. Li HL, Yin R, Chen D, et al. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy. J Cell Biochem. 2007;100:1086-1099.
12. Custodis F, Eberl M, Kilter H, et al. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy. Cardiovasc Res. 2006;71:342-351.
13. Filipeanu CM, Zhou F, Wu G. Analysis of Rab1 function in cardiomyocyte growth. Methods Enzymol. 2008;438:217-226.
14. van de Vrie M, Heymans S, Schroen B. MicroRNA involvement in immune activation during heart failure. Cardiovasc Drugs Ther. 2011;25:161-170.
15. Lu Y, Zhang Y, Wang N, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation. 2010;122:2378-2387.
16. Neth P, Nazari-Jahantigh M, Schober A, et al. MicroRNAs in flowdependent vascular remodelling. Cardiovasc Res. 2013;99:294-303.
17. Chen K, Fan W, Wang X, et al. MicroRNA-101 mediates the suppressive effect of laminar shear stress on mTOR expression in vascular endothelial cells. Biochem Biophys Res Commun. 2012;427:138-142.
18. Smits M, Mir SE, Nilsson RJ, et al. Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2. PLoS One. 2011;6:e16282.
19. Su H, Yang JR, Xu T, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009;69:1135-1142.
20. Wang L, Zhang X, Jia LT, et al. c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology. 2014;59:1850-1863.
21. Buechner J, Tomte E, Haug BH, et al. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br J Cancer. 2011;105:296-303.
22. Cao P, Deng Z, Wan M, et al. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/ HIF-1beta. Mol Cancer. 2010;9:108.
23. Strillacci A, Griffoni C, Sansone P, et al. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res. 2009;315:1439-1447.
24. Cheng J, Guo S, Chen S, et al. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis. Cell Rep. 2013;5:471-481.
25. Loirand G, Sauzeau V, Pacaud P. Small G proteins in the cardiovascular system: physiological and pathological aspects. Physiol Rev. 2013;93:1659-1720.
26. Duvernay MT, Filipeanu CM, Wu G. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell Signal. 2005;17:1457-1465.